カテゴリ： GlobalData, インド, 企業調査

Meril Life Sciences Pvt Ltd：企業の製品パイプライン分析2018

◆英語タイトル：Meril Life Sciences Pvt Ltd - Product Pipeline Analysis, 2018 Update
◆商品コード：DATA904C12182
◆発行会社（調査会社）：GlobalData
◆発行日：2018年12月
◆ページ数：33
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：インド
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD1,500 ⇒換算￥222,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD2,250 ⇒換算￥333,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Meril Life Sciences Pvt Ltd (Meril) is a medical device company that develops and designs clinically relevant devices. The company’s product categories include cardiovascular devices, vascular interventional devices, orthopedic devices, in-vitro diagnostics devices and endo-surgery devices. It offers coronary drug eluting stents, coronary bare metal stents, PTCA balloon dilatation catheter, bioresorbable scaffold, trans-catheters, knee systems and acetabular cup systems, IVD analyzers and reagents, surgical sutures, tissue sealants, absorbable hemostats, mesh, intra uterine devices, access devices, lab consumables, energy devices and staplers, accessories, and others. The company markets its products through direct sales, distributors and representatives offices located in India, Germany, Turkey, the US, China and Brazil. Meril is headquartered in Vapi, Gujarat, India.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Meril Life Sciences Pvt Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Meril Life Sciences Pvt Ltd Company Overview 5
Meril Life Sciences Pvt Ltd Company Snapshot 5
Meril Life Sciences Pvt Ltd Pipeline Products and Ongoing Clinical Trials Overview 5
Meril Life Sciences Pvt Ltd – Pipeline Analysis Overview 7
Meril Life Sciences Pvt Ltd – Key Facts 7
Meril Life Sciences Pvt Ltd – Major Products and Services 8
Meril Life Sciences Pvt Ltd Pipeline Products by Development Stage 10
Meril Life Sciences Pvt Ltd Ongoing Clinical Trials by Trial Status 12
Meril Life Sciences Pvt Ltd Pipeline Products Overview 15
BioMime 15
BioMime Product Overview 15
BioMime Clinical Trial 16
BIOMIME AURA 18
BIOMIME AURA Product Overview 18
BIOMIME AURA Clinical Trial 19
Credence – Peripheral BRS 20
Credence – Peripheral BRS Product Overview 20
Credence – Peripheral BRS Clinical Trial 21
Crypton Stainless Steel Coronary Stent System 22
Crypton Stainless Steel Coronary Stent System Product Overview 22
MeRes100 23
MeRes100 Product Overview 23
MeRes100 Clinical Trial 24
Myval Transcatheter Aortic Valve Replacement System 25
Myval Transcatheter Aortic Valve Replacement System Product Overview 25
NEXGEN Cobalt Chromium Coronary Stent System 26
NEXGEN Cobalt Chromium Coronary Stent System Product Overview 26
Meril Life Sciences Pvt Ltd – Key Competitors 27
Meril Life Sciences Pvt Ltd – Key Employees 28
Meril Life Sciences Pvt Ltd – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Appendix 30
Methodology 30
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Meril Life Sciences Pvt Ltd Pipeline Products and Ongoing Clinical Trials Overview 5
Meril Life Sciences Pvt Ltd Pipeline Products by Equipment Type 6
Meril Life Sciences Pvt Ltd Pipeline Products by Indication 6
Meril Life Sciences Pvt Ltd Ongoing Clinical Trials by Trial Status 6
Meril Life Sciences Pvt Ltd, Key Facts 7
Meril Life Sciences Pvt Ltd, Major Products and Services 8
Meril Life Sciences Pvt Ltd Number of Pipeline Products by Development Stage 10
Meril Life Sciences Pvt Ltd Pipeline Products Summary by Development Stage 11
Meril Life Sciences Pvt Ltd Ongoing Clinical Trials by Trial Status 12
Meril Life Sciences Pvt Ltd Ongoing Clinical Trials Summary 13
BioMime - Product Status 15
BioMime - Product Description 15
BioMime - A Prospective, Active Control Open Label, Multicenter Randomized Clinical Trial for Comparison Between BioMime Sirolimus Eluting Stent of and Xience Everolimus Eluting Stent to Evaluate Efficacy and Safety in Coronary Artery Disease 16
BioMime - A Prospective, Active Control, Open-label, Multi-center, Randomized Clinical trial comparing BioMime Branch - Sirolimus Eluting Coronary Side Branch Stent System Versus Xience family of Everolimus Eluting Coronary Stent System to Evaluate Safety and Performance in Patients with de Novo Coronary Bifurcation Lesions 16
BioMime - A Prospective, Single-arm, Multi-center, Observational, Real World Registry to Evaluate Safety and Performance of the BioMime Morph Sirolimus Eluting Coronary Stent System for Very Long Coronary Lesions. 16
BioMime - Biomime Biosorbable Polymer Sirolimus-eluting Stent in All-comers Patients Treated with Percutaneous Coronary Interventions: The BELLINI Registry 17
BioMime - Randomized Study to Evaluate Segmental Late Loss Comparing Two PCI Strategies Using a Long Stent Versus 2 Shorter Stents to Treat Long or Tandem Coronary Stenosis 17
BioMime - Real World Drug-eluting Stent Prospective, Open, Multi-site, Registry in Korea: BioMime Stent, Ultimaster Stent Versus Xience Stent by SMart Angioplastry Research Team: SMARTDESK-MX 17
BIOMIME AURA - Product Status 18
BIOMIME AURA - Product Description 18
BIOMIME AURA - A Prospective, Active Control, Open-label, Multi-center, Randomized Clinical trial comparing BioMime Branch - Sirolimus Eluting Coronary Side Branch Stent System Versus Xience family of Everolimus Eluting Coronary Stent System to Evaluate Safety and Performance in Patients with de Novo Coronary Bifurcation Lesions 19
BIOMIME AURA - Randomized Study to Evaluate Segmental Late Loss Comparing Two PCI Strategies Using a Long Stent Versus 2 Shorter Stents to Treat Long or Tandem Coronary Stenosis 19
Credence - Peripheral BRS - Product Status 20
Credence - Peripheral BRS - Product Description 20
Credence - Peripheral BRS - A Prospective, Multicentered and Open Label Clinical Study to Evaluate Safety and Performance of Credence Btk Sirolimus Eluting Bioresorbable Peripheral Scaffold System in Subjects with Critical Limb Ischemia Following Percutaneous Transluminal Angioplasty of Below the Knee Arteries 21
Credence - Peripheral BRS - Credence BRS 1: A Prospective, Open Label and Multicentric Clinical Study to Evaluate Safety and Performance of Credence BRS Sirolimus Eluting Bioresorbable Peripheral Scaffold System in Subjects with De Novo Native Peripheral Artery Lesions 21
Crypton Stainless Steel Coronary Stent System - Product Status 22
Crypton Stainless Steel Coronary Stent System - Product Description 22
MeRes100 - Product Status 23
MeRes100 - Product Description 23
MeRes100 - A Multi Center Randomized Control Study of MeRes100 Sirolimus Eluting BioResorbable Vascular Scaffold System in Treatment of Coronary Artery Disease Patients: MeRes - China 24
MeRes100 - A Prospective, Multinational, Multicenter, Single Arm, Open Label, Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System in the Treatment of De-novo Native Coronary Artery Lesions (MeRes-1 Extend) 24
Myval Transcatheter Aortic Valve Replacement System - Product Status 25
Myval Transcatheter Aortic Valve Replacement System - Product Description 25
NEXGEN Cobalt Chromium Coronary Stent System - Product Status 26
NEXGEN Cobalt Chromium Coronary Stent System - Product Description 26
Meril Life Sciences Pvt Ltd, Key Employees 28
Meril Life Sciences Pvt Ltd, Other Locations 29
Meril Life Sciences Pvt Ltd, Subsidiaries 29
Glossary 32

List of Figures
Meril Life Sciences Pvt Ltd Pipeline Products by Equipment Type 6
Meril Life Sciences Pvt Ltd Pipeline Products by Development Stage 10
Meril Life Sciences Pvt Ltd Ongoing Clinical Trials by Trial Status 12

★海外企業調査レポート[Meril Life Sciences Pvt Ltd：企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • The Goldman Sachs Group Inc (GS)：企業の財務・戦略的SWOT分析
    The Goldman Sachs Group Inc (GS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Takeda Pharmaceuticals International AG-製薬・医療分野：企業M&A・提携分析
    Summary Takeda Pharmaceuticals International AG (Takeda), a subsidiary of Takeda Pharmaceutical Company Ltd is a developer, manufacturer and distributor of pharmaceutical products. The company offers treatments in respiratory and immunology, central nervous system, cardiovascular and metabolic, canc …
  • PGE Polska Grupa Energetyczna SA (PGE)：企業の財務・戦略的SWOT分析
    PGE Polska Grupa Energetyczna SA (PGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Van Oord nv：電力：M&Aディール及び事業提携情報
    Summary Van Oord nv (Van Oord), a subsidiary of MerweOord BV, is a contracting company. It is specialized in dredging, marine engineering and offshore projects including oil, gas, and wind. The company primarily undertakes dredging, offshore oil and gas and offshore wind projects. Its activities inc …
  • Hong Leong Bank Bhd：企業の戦略・SWOT・財務分析
    Hong Leong Bank Bhd - Strategy, SWOT and Corporate Finance Report Summary Hong Leong Bank Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Teck Resources Ltd：企業のM&A・事業提携・投資動向
    Teck Resources Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Teck Resources Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Tektronix, Inc.：企業の戦略的SWOT分析
    Tektronix, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Motif Bio Plc (MTFB)：製薬・医療：M&Aディール及び事業提携情報
    Summary Motif Bio Plc (Motif Bio), formerly Motif Bio Ltd, is a clinical-stage biopharmaceutical company that focuses on the development of novel antibiotics to treat patients with infections caused by multi-drug resistant bacteria. The company develops Iclaprim, a targeted Gram-positive1 antibiotic …
  • DURECT Corp (DRRX)：医療機器：M&Aディール及び事業提携情報
    Summary DURECT Corp (Durect) is a specialty pharmaceutical company. It carries out the development of pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. It also undertakes the development of biotechnology products. The company’s …
  • Main Line Health System：企業の戦略的SWOT分析
    Main Line Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Chong Kun Dang Pharmaceutical Corp (185750)：製薬・医療：M&Aディール及び事業提携情報
    Summary Chong Kun Dang Pharmaceutical Corp (CKD Pharma) manufactures, distributes, imports and exports prescription drugs, active pharmaceutical ingredients (APIs), over-the-counter (OTC) drugs, health supplements and consumer health products. Its product portfolio includes prescription products for …
  • IntelliCell BioSciences Inc：企業の戦略的SWOT分析
    IntelliCell BioSciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Sientra Inc (SIEN)：企業の財務・戦略的SWOT分析
    Summary Sientra Inc (Sientra) is a medical device company that manufactures and markets plastic surgery implantable devices. The company’s products comprise breast implants, breast tissue expanders, silicone scar treatment and additional tissue expanders. It offers reconstructive surgery devices suc …
  • Baumot Group AG (TINC)：企業の財務・戦略的SWOT分析
    Baumot Group AG (TINC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • X-ELIO Energy SL：電力：M&Aディール及び事業提携情報
    Summary X-ELIO Energy SL (X-ELIO), formerly Gestamp Solar, a subsidiary of Corporacion Gestamp S.L. is an alternative energy company that operates utility scale photovoltaic power plants. The company constructs, designs, installs, develops, and maintains solar photovoltaic plants. Its development, c …
  • Atlas Copco AB (ATCO A)：石油・ガス：M&Aディール及び事業提携情報
    Summary Atlas Copco AB (Atlas Copco) is a provider of industrial productivity solutions. It develops and manufactures vacuum solutions, air treatment systems, compressors, assembly systems, construction and mining equipment, and power tools. The company’s products include vacuum solutions and air tr …
  • Pioneer Energy Services Corp (PES)：企業の財務・戦略的SWOT分析
    Pioneer Energy Services Corp (PES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Rubis SCA (RUI)：企業の財務・戦略的SWOT分析
    Rubis SCA (RUI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • FirstRand Private Bank：企業の戦略・SWOT・財務情報
    FirstRand Private Bank - Strategy, SWOT and Corporate Finance Report Summary FirstRand Private Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • U.S. HealthWorks Medical Group：企業のM&A・事業提携・投資動向
    U.S. HealthWorks Medical Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's U.S. HealthWorks Medical Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆